Skip to main content
. 2016 Jan 27;7(7):8321–8331. doi: 10.18632/oncotarget.7032

Table 2. SETDB1 mutations identified in 78 MPMs from 69 patients and previously reported.

ID Protein change aNucleotide change Mutation type dPolyPhen-2 eSIFT Predicted function Mutant ratio
777T Y249X 747T>A nonsense Loss of function 0.91
869T G869E 2606G>A missense damaging damaging Damaging 0.51
163T C911F 2732G>T missense damaging tolerated Uncertain 0.49
324T S947C 2840C>G missense benign damaging Uncertain 0.61
970T P226RfsX4 677_693del17 frameshift Loss of function 0.19
981T P226RfsX4 677_693del17 frameshift Loss of function 0.23
1278T F1250del 3747_3749del in-frame del Uncertain 0.14
bACCMESO1 V132EfsX3 395_399del5 frameshift Loss of function
cNYU695 K674SfsX73 2020delA frameshift Loss of function
b

Previously reported mutation: ACCMESO1 - V132fs (CCLE, http://www.broadinstitute.org/ccle)

c

Previously reported mutation: NYU695 - p.K674fs [18]